FDA Inspection 800544 — Grifols Canada Plasma II Inc.
The FDA completed an inspection of Grifols Canada Plasma II Inc. on Aug 16, 2012 in Winnipeg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Winnipeg (Canada)